Related Experiment Video
Updated: Sep 16, 2025

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
Venom versatility: Dynamic anticoagulant and procoagulant variations between and within Bothrocophias (toad-head) and
Lachlan A Bourke1, David Salazar-Valenzuela2, Marco Mancuso3
1Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St Lucia, QLD, 4072, Australia.
Abstract:
Pinpointing the emergence of toxicological evolutionary novelties can be challenging. In American pit vipers, anticoagulant venoms are the paradigm, with a notable exception being the genus Bothrops, which are typically procoagulant. A recent study found that the basal Bothrops (B. pictus) is anticoagulant, raising two competing hypotheses: ancestral Bothrops were anticoagulant with procoagulant venom evolving later, or ancestral Bothrops were procoagulant with anticoagulant venom in B. pictus being a derived trait. To help resolve this, we tested venoms of the sister genus Bothrocophias for pathophysiological actions upon blood clotting. The Ecuadorian Bothrocophias venoms (B. campbelli, B. lojanus, and B. microphthalmus) were compared to Bothrops pictus. Both Bothrocophias lojanus and B. pictus inhibited various blood clotting enzymes, but B. pictus was more potently anticoagulant. Intriguingly, B. campbelli and B. microphthalmus were procoagulant. Both B. microphthalmus populations activated prothrombin, but Zamora Chinchipe locality also activated Factors X and VII. Bothrocophias campbelli showed a novel activity, using Factor Va in a calcium-dependent manner as a cofactor to activate prothrombin, the first time this has been shown for any viperid venom. Organismal phylogenetics failed to resolve the relative positions of B. campbelli and B. lojanus, thus we were unable to ascertain the ancestral trait. To resolve this, more phylogenetic research and venom testing with other Bothrocophias species is needed. Neutralisation tests revealed differential efficacy of PoliVal-ICP (Instituto Clodomiro Picado) and Soro Antibotrópico (Instituto Butantan) antivenoms. Together, these findings aid in designing evidence-based clinical-management strategies and provide foundational data for reconstructing venom evolution.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Predator-Prey Interactions
Convergent Evolution
Venous Thrombosis III: Interprofessional Care

